CSF MAP-2 IN TRAUMATIC BRAIN INJURY
CSF MAP-2 IN TRAUMATIC BRAIN INJURY
批准号:
2793074
负责人:
FRANK P ZEMLAN
金额:
$10.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-08-01 至 2000-07-31
中文摘要
描述:(申请人摘要)本提案的目的是开发一种量化急性神经元变性的实验室测试。这种测试需要用于几种临床适应症,包括创伤性脑损伤(TBI)以及神经保护剂药物试验的分期患者。拟议的实验室测试将量化微管相关蛋白2 (MAP-2)的水平。MAP-2是一种主要定位于神经元细胞体和树突的神经元特异性蛋白。在正常情况下,MAP-2不会从神经元中释放。然而,我们的初步Western blot研究表明,在神经元损伤(TBI)患者后,脑脊液(CSF)中MAP-2水平升高,而对照组脑脊液中MAP-2水平未检测到。拟议的研究将产生单克隆抗体(mab),识别人脑脊液中发现的MAP-2的形式。将针对从TBI患者和对照脑脊液中筛选的脑脊液MAP-2纯化的CSN创伤脑和杂交瘤建立单克隆抗体,以确保单克隆抗体识别脑脊液MAP-2。这些MAP-2单克隆抗体将用于开发CSF MAP-2 ELISA。开发的MAP-2 ELISA将用于筛选TBI患者(N=30)和对照组(N=61)的脑脊液,包括脱髓鞘疾病、脑积水、背痛和偏头痛患者。将脑脊液MAP-2水平与住院期间TBI患者的格拉斯哥昏迷量表评分进行比较,确定患者临床改善与脑脊液MAP-2水平的关系。将确定初始脑脊液MAP-2水平预测TBI患者出院时临床结局(格拉斯哥结局评分)的能力。拟议的商业应用:该I期申请的目的是开发一种体外测试,用于识别与创伤性脑损伤相关的神经元损伤。
英文摘要
DESCRIPTION: (Applicant's abstract) The objective of this proposal is to develop a laboratory test for quantifying acute neuronal degeneration. Such a test is needed for several clinical indications including traumatic brain injury (TBI) as well as staging patients for drug trials of neuroprotective agents. The proposed laboratory test will quantify levels of microtubule-associated protein 2 (MAP-2). MAP-2 is a neuron-specific protein localized primarily in neuronal cell bodies and dendrites. Under normal conditions MAP-2 is not released from neurons. However, our preliminary Western blot studies indicate that after neuronal injury (TBI patients) cerebrospinal fluid (CSF) MAP-2 levels are elevated while MAP-2 levels in control CSF were not detectable. The proposed studies will raise monoclonal antibodies (Mabs) that recognize the form of MAP-2 found in human CSF. Mabs will be raised against MAP-2 purified form CSN trauma brain and hybridomas screened against CSF from TBI patients and control CSF to insure that Mabs recognize CSF MAP-2. These MAP-2 Mabs will be employed to develop a CSF MAP-2 ELISA. The developed MAP-2 ELISA will be used to screen CSF from TBI patients (N=30) and controls (N=61) including patients with a demyelinating disease, hydrocephalus, back pain and migraine. The relationship between patient clinical improvement and CSF MAP-2 levels will be determined by comparing CSF MAP-2 levels with the Glasgow Coma Scale scores of TBI patients during hospitalization. The ability of initial CSF MAP-2 levels to predict the clinical outcome (Glasgow Outcome Score) of TBI patients at discharge will be determined. PROPOSED COMMERCIAL APPLICATION: The purpose of this Phase I application is to develop an in vitro test for identifying neuronal injury associated with traumatic brain damage.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COCAINE THERAPEUTIC: PD2005 DOPAMINE TRANSPORT INHIBITOR
-
批准号:6785636
-
项目类别:
-
资助金额:$13.65万
-
财政年份:2004
-
负责人:FRANK P ZEMLAN
-
依托单位:
Serum C-tau Precition of Brain Damage in Mild TBI
-
批准号:6689352
-
项目类别:
-
资助金额:$12.86万
-
财政年份:2003
-
负责人:FRANK P ZEMLAN
-
依托单位:
Biomarker for Subarachnoid Hemorrhage
-
批准号:6483618
-
项目类别:
-
资助金额:$12.81万
-
财政年份:2002
-
负责人:FRANK P ZEMLAN
-
依托单位:
Melatonin Analog for Sleep Disorders
-
批准号:6712083
-
项目类别:
-
资助金额:$46.32万
-
财政年份:2002
-
负责人:FRANK P ZEMLAN
-
依托单位:
Melatonin Analog for Sleep Disorders
-
批准号:6707905
-
项目类别:
-
资助金额:$50.43万
-
财政年份:2002
-
负责人:FRANK P ZEMLAN
-
依托单位:
Biomarker of Neuronal Damage in Traumatic Brain Injury
-
批准号:6598070
-
项目类别:
-
资助金额:$23.69万
-
财政年份:2001
-
负责人:FRANK P ZEMLAN
-
依托单位:
Biomarker of Neuronal Damage in Traumatic Brain Injury
-
批准号:6612652
-
项目类别:
-
资助金额:$25.73万
-
财政年份:2001
-
负责人:FRANK P ZEMLAN
-
依托单位:
Biomarker of Neuronal Damage in Traumatic Brain Injury
-
批准号:6529679
-
项目类别:
-
资助金额:$27.07万
-
财政年份:2001
-
负责人:FRANK P ZEMLAN
-
依托单位:
Biomarker of Neuronal Damage in Traumatic Brain Injury
-
批准号:6650523
-
项目类别:
-
资助金额:$4.08万
-
财政年份:2001
-
负责人:FRANK P ZEMLAN
-
依托单位:
Neurotoxin Discovery Platform - Drugs of Abuse
-
批准号:6743783
-
项目类别:
-
资助金额:$24.31万
-
财政年份:2000
-
负责人:FRANK P ZEMLAN
-
依托单位:
Neurotoxin Discovery Platform - Drugs of Abuse
-
批准号:6626012
-
项目类别:
-
资助金额:$23.6万
-
财政年份:2000
-
负责人:FRANK P ZEMLAN
-
依托单位:
NEUROTOXIN DISCOVERY PLATFORM - DRUGS OF ABUSE
-
批准号:6135366
-
项目类别:
-
资助金额:$10.8万
-
财政年份:2000
-
负责人:FRANK P ZEMLAN
-
依托单位:
Neurotoxin Discovery Platform - Drugs of Abuse
-
批准号:6484021
-
项目类别:
-
资助金额:$26.18万
-
财政年份:2000
-
负责人:FRANK P ZEMLAN
-
依托单位:
SERUM MAP-TAU IN TRAUMATIC BRAIN INJURY
-
批准号:6071321
-
项目类别:
-
资助金额:$10.71万
-
财政年份:2000
-
负责人:FRANK P ZEMLAN
-
依托单位:
HUMAN SERUM BIOMARKER FOR NEUROTOXICITY
-
批准号:6210766
-
项目类别:
-
资助金额:$10.48万
-
财政年份:2000
-
负责人:FRANK P ZEMLAN
-
依托单位:
CSF AND PLASMA NEUROFILAMENTS IN TRAUMATIC BRAIN INJURY
-
批准号:6015713
-
项目类别:
-
资助金额:$10.0万
-
财政年份:1999
-
负责人:FRANK P ZEMLAN
-
依托单位:
DOPAMINE FUNCTIONAL SUBTYPES OF SCHIZOPHRENIA
-
批准号:3378322
-
项目类别:
-
资助金额:$16.71万
-
财政年份:1986
-
负责人:FRANK P ZEMLAN
-
依托单位:
DOPAMINE FUNCTIONAL SUBTYPES OF SCHIZOPHRENIA
-
批准号:3378320
-
项目类别:
-
资助金额:$15.44万
-
财政年份:1986
-
负责人:FRANK P ZEMLAN
-
依托单位:
DOPAMINE FUNCTIONAL SUBTYPES OF SCHIZOPHRENIA
-
批准号:3378321
-
项目类别:
-
资助金额:$16.47万
-
财政年份:1986
-
负责人:FRANK P ZEMLAN
-
依托单位:
PEPTIDE/MONOAMINE CONTROL OF SPINAL PAIN TRANSMISSION
-
批准号:3398369
-
项目类别:
-
资助金额:$11.69万
-
财政年份:1983
-
负责人:FRANK P ZEMLAN
-
依托单位:
海外基金